Chesnara Plc: Fourth acquisition in two years
12 November 2026
Autolus Therapeutics plc (NASDAQ: AUTL), a UK-based clinical-stage biopharmaceutical company, is generating significant buzz among investors, largely due to its compelling potential upside of 273.74%. Specializing..
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is capturing the attention of the investment community with its promising pipeline in the biotechnology sector, specifically targeting inflammatory and immunology..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is a standout in the biotechnology sector, capturing investor interest with its impressive potential upside of nearly 70%. Specializing in innovative..
Neuropace, Inc. (NPCE), a healthcare sector player specializing in medical devices, has captured investor attention with its innovative approach to treating drug-resistant epilepsy through its RNS..
Nuvation Bio Inc. (NASDAQ: NUVB), a promising player in the biotechnology sector, is capturing investor attention with an impressive potential upside of 185.52%. Despite its current..
MeiraGTx Holdings plc (NASDAQ: MGTX) stands at the forefront of pioneering gene therapy treatments, capturing the attention of investors with its promising pipeline and notable growth..
Individual investors looking for opportunities in the healthcare sector may find Standard BioTools Inc. (NASDAQ: LAB) an intriguing option. With a market capitalization of approximately $531.03..
Investors are taking a closer look at PureTech Health plc (NASDAQ: PRTC), a dynamic player in the biotechnology sector with a promising pipeline of therapeutic innovations...
Prothena Corporation plc (NASDAQ: PRTA), a pioneering force in the biotechnology sector, presents a compelling case for investors with its significant upside potential of 262.47%. Based..
For investors with a keen interest in the biotechnology sector, Geron Corporation (NASDAQ: GERN) presents a compelling case, especially with its striking potential upside of 164.76%...
ATAI Life Sciences N.V. (NASDAQ: ATAI) stands at the forefront of the biotechnology sector, with a unique focus on developing innovative treatments for mental health disorders...
Myriad Genetics, Inc. (NASDAQ: MYGN), a pivotal player in the healthcare sector, stands at the intersection of molecular diagnostics and precision medicine. Headquartered in Salt Lake..
Cross Country Healthcare, Inc. (NASDAQ: CCRN) is currently a focal point for investors eyeing the healthcare sector. With a market capitalization of approximately $441.33 million, this..
Vir Biotechnology, Inc. (NASDAQ: VIR) is capturing attention in the biotech investment arena with its compelling potential upside of 210.33%, as indicated by analyst ratings. This..
RxSight, Inc. (NASDAQ: RXST), a commercial-stage medical technology company, is making waves in the healthcare sector with its innovative approach to cataract surgery. Specializing in the..
OrthoPediatrics Corp. (NASDAQ: KIDS) stands out in the healthcare sector, specifically within the medical devices industry, as a company focused on the unique needs of pediatric..
For investors with a keen eye on the healthcare sector, Sonida Senior Living, Inc. (SNDA) represents a compelling opportunity in the niche of senior housing. Based..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a dynamic player in the healthcare sector specializing in treatments for rare diseases, presents a tantalizing opportunity for investors seeking high-growth..
Individual investors eyeing opportunities in the biotechnology sector may find Celcuity Inc. (NASDAQ: CELC) an intriguing prospect. This Minneapolis-based company, with a market capitalization of $532.02..
